Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.
about
Pharmacotherapies for sleep disturbances in Alzheimer's diseaseMelatonin for the treatment of dementiaClinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies'The clocks that time us'--circadian rhythms in neurodegenerative disordersSynchronizing an aging brain: can entraining circadian clocks by food slow Alzheimer's disease?Sleep, circadian rhythms, and the pathogenesis of Alzheimer diseaseSleep disturbance in mental health problems and neurodegenerative diseaseEvaluation of the efficacy of randomized controlled trials of sensory stimulation interventions for sleeping disturbances in patients with dementia: a systematic review.Neurodegeneration and the Circadian Clock.The antiapoptotic activity of melatonin in neurodegenerative diseases.Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.The circadian clock and pathology of the ageing brain.A systematic mapping review of randomized controlled trials (RCTs) in care homesTherapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.Treatment of sleep disturbance in Alzheimer's dementia.The sleep-wake cycle and Alzheimer's disease: what do we know?Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trialMedication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design.Evaluation and management of the elderly patient presenting with cognitive complaints.Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials.Neuropsychiatric symptoms in Alzheimer's diseaseEffect of home-based light treatment on persons with dementia and their caregivers.Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease.Melatonin Therapy in Patients with Alzheimer's Disease.Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults.Insomnia and dementia: is agomelatine treatment helpful? Case report and review of the literature.Evidence-based recommendations for the assessment and management of sleep disorders in older personsA hypnic hypothesis of Alzheimer's disease.Sleep in psychiatric disorders: where are we now?Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.Delirium superimposed on dementia and mild cognitive impairment.Review of information and communication technology devices for monitoring functional and cognitive decline in Alzheimer's disease clinical trials.Agitation and aggression in Alzheimer's disease: an update on pharmacological and psychosocial approaches to care.Monoaminergic neuropathology in Alzheimer's disease.Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases.Treatment of Sleep Disorders in DementiaMeasurement of Neuropsychiatric Symptoms in Clinical Trials Targeting Alzheimer's Disease and Related Disorders.
P2860
Q24197895-4F1D8234-9CD4-43FB-BFC6-7D51A869A682Q24244870-1624AE2E-340C-460A-A7E7-AAB0235D50DBQ26772851-B40D882B-0E66-4FC3-8022-4D58D2C574FEQ26824646-909D5DAF-F26E-4556-BC14-924A4EDCF6DFQ27011370-84B6A330-2A30-4192-B0ED-CAD85130806CQ27024779-2E1D68F2-87DD-48B2-A68B-8AAD2B180B29Q28681847-BB9F5EFC-2C5A-4700-AAC3-6D766D673B93Q30400537-1F92D65A-1D56-4A5F-9820-4931C74AE385Q33736479-3BB4A473-8228-4DBF-BFA3-C28191C7F1C6Q33757816-A423BDAD-D9DA-4257-9537-E224B87993E5Q33800161-54D0A32D-F4A0-41B9-9D56-78F106F85CD9Q34259247-10F072B9-D09E-46FD-9E17-C761B9CBBD73Q34316513-1BCC7A68-BAEB-4CD9-ACB7-DDF8DF771CA0Q34358480-71CA07E0-CBFB-4F32-9815-52ED386C7241Q34416921-DDB3DEA3-CF3F-423E-A7DA-9C67DCEB00A8Q34452896-5E897312-4F14-4C76-9818-2DE0FD9D3DA9Q34623833-6E1E8903-939D-43F2-BA96-8C8F87C4EBAAQ34637928-A7D0FCDA-FFAE-4093-A16A-D3F178BE7337Q35171044-526D6B21-F2E0-48A8-A0B5-DD22FE005F58Q35185368-69B6D48A-8692-4D35-AEC1-3E4EDBB39586Q35447239-6E8A1B53-8E14-467B-A6DA-D65527FF685DQ35547735-DC210793-3566-4839-BE1A-89D3EC368F77Q35823575-814F19A1-49D8-4081-814A-21934D9AE49EQ35934151-6A1FD22D-726C-4501-9088-E3B734E3B177Q36137410-86A96B28-42A1-4F4C-AFF6-52C23F137E6EQ36335048-68E11132-FA62-4AD3-888B-CD4A43AE4A4AQ36928856-18354B45-E379-48AE-9ED3-2CE099100D3CQ37148272-0CB0C529-AF50-4C21-9A1B-D175B7A0EC2BQ37356250-73F47615-D7B5-4EFB-93F1-B195AD961D03Q37446899-76785AB3-4E47-4F60-AFC0-515245776141Q37779583-BDE549C4-AAD0-4F19-86AD-3011F9628C44Q38022179-441CB398-7F6F-48F9-A75A-1FE4E5A3B893Q38253060-13E06F39-C44F-4668-A5AE-E174FD793807Q38270211-1DED8EED-FD8E-428C-B2AC-0810B3417A26Q38364551-D56BE954-B852-4BBB-AE7E-0B63D4A82A72Q38364828-4CC4668C-0ECC-4722-8D83-1494BA329AF3Q38809649-E214857D-B2E5-41C3-84B0-1CFE552E43AFQ38834700-A76425AD-EB9B-4AD8-85C0-E1BFEE9B437CQ38913876-C88FC4C2-93DE-4B01-AD76-BE55D66B52E3Q38974408-41501A32-2068-4663-AEAB-B9D37E216113
P2860
Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Melatonin fails to improve sle ...... tients with Alzheimer disease.
@en
Melatonin fails to improve sle ...... tients with Alzheimer disease.
@nl
type
label
Melatonin fails to improve sle ...... tients with Alzheimer disease.
@en
Melatonin fails to improve sle ...... tients with Alzheimer disease.
@nl
prefLabel
Melatonin fails to improve sle ...... tients with Alzheimer disease.
@en
Melatonin fails to improve sle ...... tients with Alzheimer disease.
@nl
P2093
P2860
P921
P1476
Melatonin fails to improve sle ...... tients with Alzheimer disease.
@en
P2093
Donald J Connor
Jennifer L Martin
Jody Corey-Bloom
Philip R Gehrman
Tamar Shochat
P2860
P304
P356
10.1097/JGP.0B013E318187DE18
P577
2009-02-01T00:00:00Z